Nothing is standard about the study design, study conduct or the regulatory process in cell and gene therapy trials. Every cell and gene therapy is different due to the specific characteristics of each product, with a complicated regulatory approval process and unique therapeutic challenges.
Read More
Study start-up and post-go-live protocol amendments can be lengthy, costly, and disruptive to a clinical trial. But with the right technology, data managers can accelerate timelines and overcome these challenges.
Read More
Meet Veristat at the Virtual event taking place October 12-14, 2020.
Read More
Meet Veristat at the Virtual event taking place 26-28 October 2020.
Read More
As the world begins to relax restrictions, what are the lessons learned that can catapult us into the next innovation in trial operations for good?
Read More
Submitting an Investigational New Drug (IND) application to the US FDA is a significant step in the development of a new drug or biologic product. But, are you ready?
Read More
Meet Veristat at the Virtual US DIA Annual Meeting 2020 taking place on 14-18 June 2020, Virtual Booth #138
Read More
Meet Veristat at the ASCO 2020, 30 May – 1 June 2020, Booth 25110
Read More
Connect with Veristat at the CMO Summit, 26-27 October, 2020
Read More
As of 11 March 2020- This event is being postponed until early 2020 due to Covid-19 Pandemic
Read More
